Osaic Holdings’s AC Immune ACIU Stock Holding History

Osaic Holdings’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$523	Sell	220 -1	-0.5%	-$3	﹤0.01%	7638
2026 Q1	$607	Hold	221	–	–	﹤0.01%	7391
2025 Q4	$693	Sell	221 -30	-12%	-$95	﹤0.01%	7375
2025 Q3	$724	Hold	251	–	–	﹤0.01%	7455
2025 Q2	$509	Buy	+251	New	+$437	﹤0.01%	7345
2024 Q1	–	Sell	-2,000	Closed	-$10K	–	7187
2023 Q4	$10K	Hold	2,000	–	–	﹤0.01%	5830
2023 Q3	$5.7K	Hold	2,000	–	–	﹤0.01%	6211
2023 Q2	$5.91K	Hold	2,000	–	–	﹤0.01%	6229
2023 Q1	$4.68K	Hold	2,000	–	–	﹤0.01%	6354
2022 Q4	$4K	Hold	2,000	–	–	﹤0.01%	6364
2022 Q3	$6K	Sell	2,000 -1,000	-33%	-$3.15K	﹤0.01%	6250
2022 Q2	$11K	Sell	3,000 -100	-3%	-$342	﹤0.01%	5999
2022 Q1	$12K	Sell	3,100 -1,100	-26%	-$4.76K	﹤0.01%	6009
2021 Q4	$21K	Hold	4,200	–	–	﹤0.01%	5746
2021 Q3	$28K	Buy	4,200 +3,200	+320%	+$22.9K	﹤0.01%	5525
2021 Q2	$8K	Hold	1,000	–	–	﹤0.01%	6174
2021 Q1	$8K	Buy	+1,000	New	+$7.14K	﹤0.01%	5968

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's ACIU Position: Q2 2026 in Review

Osaic Holdings reduced its AC Immune (ACIU) stake by 0.45% in Q2 2026, selling an estimated $3 and leaving 220 shares worth $523. The position accounts for ﹤0.01% of the portfolio, ranked #7638.

Osaic Holdings first reported a position in ACIU in Q1 2021 and has held it in 17 quarters since. The position peaked at $28K in Q3 2021. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

Osaic Holdings held 220 shares of AC Immune worth $523 as of Q2 2026.
Osaic Holdings sold 1 AC Immune share in Q2 2026, an estimated $3.
AC Immune made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7638 holding.
Osaic Holdings first reported a position in AC Immune in Q1 2021 and has held it in 17 quarters since.
Osaic Holdings's AC Immune position peaked at $28K in Q3 2021.
43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.